Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Citalopram hydrobromide (XU-62-320) 是一种选择性 5-羟色胺再摄取抑制剂,可选择性地抑制 CNS 神经元对 5-羟色胺的再摄取,从而增强中枢神经系统中的 5-羟色胺能活性,也具有抗抑郁活性。它抑制兔血小板中 5-HT 的摄取,IC50为 14 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
10 mg | ¥ 278 | 现货 | ||
25 mg | ¥ 452 | 现货 | ||
50 mg | ¥ 625 | 现货 | ||
100 mg | ¥ 919 | 现货 | ||
200 mg | ¥ 1,370 | 现货 | ||
500 mg | ¥ 2,290 | 现货 |
产品描述 | Citalopram hydrobromide (XU-62-320) , a selective serotonin reuptake inhibitor (SSRI), selectively inhibits the CNS neuronal reuptake of serotonin, thereby potentiating serotonergic activity in the central nervous system (CNS). Citalopram hydrobromide is the orally bioavailable hydrobromide salt of the racemic bicyclic phthalene derivative citalopram with antidepressant activity. This agent has minimal effects on the CNS neuronal reuptake of norepinephrine (NE) and dopamine (DA). |
靶点活性 | 5-HT receptor:1.8 nM |
体外活性 | Citalopram (Lu 10-171), a new bicyclic phthalane derivative, is an extremely potent inhibitor of neuronal serotonin (5-HT) uptake but has no effect on the uptake of noradrenaline(NA) and dopamine (DA) and no antagonistic activity towards 5-HT, histamine, gamma aminobutyric acid (GABA), acetylcholine, and morphine receptors. It is an extremely specific and potent inhibitor of neuronal 5-HT uptake. Uptake mechanisms for other transmitter amines are not influenced by the drug[1]. The SSRI citalopram has a greater effect on proliferation and a lesser effect on apoptotic activity. It affects cell cycle regulation by increasing proliferative potential and decreasing apoptotic activity in a site specific manner that may be indicative of hyperplasia. Citalopram alters FGF, MSX and TGFB expression in osteoblast cell culture[3]. |
体内活性 | Citalopram is devoid of cardiotoxic effects even when animals are exposed to concentrations far above the therapeutic level. In man citalopram is metabolized to compounds which are also potent 5-HT-uptake inhibitors without effect on noradrenaline(NA) uptake and which are found in lower concentrations than citalopram itself. Citalopram (1-16 mg/kg) stimulates the hind limb flexor reflex in the spinal rat. Citalopram potentiates 5-HT transmission~ possibly by producing very strong uptake inhibition without simultaneously blocking the post-synaptic 5-HT receptors[1]. |
细胞实验 | Cells are cultured in alpha minimum Eagles medium supplemented with 1% penicillin/streptomycin, 10% fetal bovine serum and Amphotericin B. For control data, cells are cultured for 3 or 7 days with standard alpha proliferation media. For SSRI treatments, media is supplemented with citalopram eluted to serially diluted doses between 10?4 mol through 10?10 mol to achieve a dose response curve.(Only for Reference) |
别名 | Lu 10-171, Nitalapram HBr, Bonitrile HBr, XU-62-320, Lu 10-171 HBr, 氢溴酸西酞普兰, Citalopram HBr |
分子量 | 405.304 |
分子式 | C20H22BrFN2O |
CAS No. | 59729-32-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 6 mg/mL(14.8 mM)
H2O: 4 mg/mL(9.9 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
Ethanol / H2O | 1 mM | 2.4673 mL | 12.3364 mL | 24.6728 mL | 61.6821 mL |
5 mM | 0.4935 mL | 2.4673 mL | 4.9346 mL | 12.3364 mL | |
Ethanol | 10 mM | 0.2467 mL | 1.2336 mL | 2.4673 mL | 6.1682 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Citalopram hydrobromide 59729-32-7 Autophagy GPCR/G Protein Neuroscience 5-HT Receptor Serotonin Transporter Citalopram SLC6A4 Lu 10-171 SERT serotonin Nitalapram HBr selective 5-HTT 5-HT,Antidepressant Bonitrile HBr (±)-Citalopram XU-62-320 Citalopram Hydrobromide reuptake Lu 10-171 HBr inhibitor 氢溴酸西酞普兰 inhibit SSRI Citalopram HBr Inhibitor